Copyright: ©Author(s) 2026.
World J Diabetes. Nov 15, 2026; 17(11): 124123
Published online Nov 15, 2026. doi: 10.4239/wjd.124123
Published online Nov 15, 2026. doi: 10.4239/wjd.124123
Table 3 Mendelian randomization analysis of the causal association between diabetes and cancer
| Diabetes (exposure) | Cancer (outcome) | Method | Single nucleotide polymorphisms | P value | OR (95%CI) | P value for pleiotropy |
| finn-b-E4_DMNAS | ukb-e-2453_CSA | IVW | 8 | 0.012 | 1.50 (1.09, 2.06) | 0.685 |
| Weighted median | 8 | < 0.001 | 1.57 (1.21, 2.05) | |||
| Simple mode | 8 | 0.049 | 1.76 (1.10, 2.81) | |||
| Weighted mode | 8 | 0.009 | 1.59 (1.23, 2.04) | |||
| MR Egger | 8 | 0.121 | 1.65 (0.96, 2.82) |
- Citation: Lu Y, Chai MS, Lan QY, Yang QM, Yang FR, Xiao TN, Kong XW, Zhou PR, Hua H. Diabetes as a pan-cancer risk factor: Triangulated evidence from global burden, longitudinal cohorts, and Mendelian randomization. World J Diabetes 2026; 17(11): 124123
- URL: https://www.wjgnet.com/1948-9358/full/v17/i11/124123.htm
- DOI: https://dx.doi.org/10.4239/wjd.124123